NCT06574438 The Effectiveness of AIFIGA Program on Nursing Home Nursing Staff and Family and Residents'Health
| NCT ID | NCT06574438 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Family |
| Study Type | INTERVENTIONAL |
| Enrollment | 210 participants |
| Start Date | 2024-09-24 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 210 participants in total. It began in 2024-09-24 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop and evaluate the longitudinal effectiveness of the Artificial Intelligence Family Involvement Generative Agent (AIFIGA) program in enhancing the health of nursing staff, family, and residents' health through the use of a sequential, mixed methods research design. The development of a real-time, interactive, and informative AIFIGA program that sparks innovation is necessary to achieve effective communication between families and nursing staff. In Phase I, lasting 18 months, we will develop the AIFIGA program based on triangulate research design, observation and in-depth interview understanding the daily communication experiences and expectations from both families and nursing staff perception in Nursing Homes(NHs) after COVID-19, as well as our previous years' research results. The training data for AIFIGA will be derived from the collection of communication dialogues in these qualitative data. Furthermore, the intelligence of AIFIGA will be developed using publicly available large language models (LLMs). In Phase II, spanning the next 18 months, we will evaluate the longitudinal effects of the AIFIGA program on the health of residents, families, and nursing staff, tracking changes over time (baseline, 1 month, 3 months, and 6 months). There will be two groups of participants: (a) an AIFIGA group that receives the AIFIGA program and uses it for 3 months, and (b) a control group that receives only routine care.
Eligibility Criteria
Inclusion Criteria: All resident-caregiver pairs meeting the inclusion criteria will be invited to join the study. 1. residents aged ≥ 60 years, resident's family were aged equal or higher than 20 years. 2. both residents and family can communicate in Mandarin or Taiwanese 3. residents have a Mini-Mental State Examination (MMSE) score equal to or higher than 16 for residents with no formal education or higher than 24 for residents with at least a primary school education 4. both residents and family agree to participate 5. the family is a significant member of the resident, such as a caregiver. For nurses and nursing aides: 1. working in the selected nursing home who agree to participate in our program. 2. aged equal or higher than 20 years. Exclusion Criteria: \-
Contact & Investigator
Hsiu Hsin Tsai, PhD
STUDY CHAIR
Chang Gung University
Frequently Asked Questions
Who can join the NCT06574438 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Family. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06574438 currently recruiting?
Yes, NCT06574438 is actively recruiting participants. Contact the research team at kitty@mail.cgu.edu.tw for enrollment information.
Where is the NCT06574438 trial being conducted?
This trial is being conducted at Hsinchu, Taiwan.
Who is sponsoring the NCT06574438 clinical trial?
NCT06574438 is sponsored by Chang Gung Memorial Hospital. The principal investigator is Hsiu Hsin Tsai, PhD at Chang Gung University. The trial plans to enroll 210 participants.